logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
05/09/2025
Nasdaq is considering speeding up the delisting process for companies with market values below $5 million.
Latest
3 m ago
European Commission President Antonio Costa: EU team will travel to Washington for sanctions negotiation.
3 m ago
According to the AI flash news of Every Media, Dongwu Securities released a research report on September 5, giving a buy rating for Yingke Renewable Energy (688087.SH). The main reasons for the rating include: 1) The proportion of finished frames and decorative building materials revenue exceeds 75%, with a 38% increase in decorative building materials revenue in 2025H1; 2) Operating cash flow net amount increased by 17.50% in 2025H1; 3) The gradual release of manufacturing capacity in Southeast Asia, increased expansion in emerging markets, and enhanced operational resilience; 4) The first midterm dividend, improving shareholder returns. (Daily Economic News)
3 m ago
Shen Textile A: Chairman Yin Kefei resigns
4 m ago
China Shipbuilding (00317.HK): Chen Liping resigns as director and general manager.
4 m ago
BioNTech's experimental breast cancer drug has been successful in trials.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.